SEATTLE, Sept. 24, 2012 - On Sunday, Sept. 23 The Seattle Times published a guest-written Health page column by Swedish-affiliated naturopathic physician Dan Labriola, N.D., headlined 'The cold facts about echinacea.'
'media' Swedish News Blog posts
Seattle Times Publishes Guest Column by Swedish-Affiliated Naturopathic Doctor on Myths and Facts about Echinacea and Cold/Flu Season
ISSAQUAH, WASH., Sept. 13, 2012 – On Wednesday, Sept. 26 from 6-7:30 p.m. at Swedish/Issaquah (751 NE Blakely Drive, Issaquah) a free community health education program will be given by two experts in esophageal conditions. The 90-minute class will examine causes of heartburn and gastroesophageal reflux disease (GERD), as well as offer practical steps for personal management and treatment.
Hundreds of Swedish-Affiliated Providers Recognized as Part of Seattle and Seattle Met Magazines' Annual Top Doctors Surveys
SEATTLE, Sept. 11, 2012 - As they do each year, Seattle magazine and Seattle Met magazines published the results of their annual Top Doctors surveys in their July and August 2012 issues, respectively. To recognize the more than 300 Swedish-affiliated providers who were nominated by their peers for each survey, here is information about both efforts.
SEATTLE, March 30, 2012 - Seattle NBC affiliate KING Television (Channel 5) aired a story during their 5 p.m. PT newscast tonight about a relatively new, FDA-approved medical device called LifeVest ®. The wearable defibrillator is a treatment option for sudden cardiac arrest that offers patients advanced protection and monitoring as well as improved quality of life.
LifeVest is the first wearable defibrillator. Unlike an implantable cardioverter defibrillator (ICD), the LifeVest is worn outside the body rather than implanted in the chest. This device continuously monitors the patient's heart with dry, non-adhesive sensing electrodes to detect life-threatening abnormal heart rhythms. If a life-threatening rhythm is detected, the device alerts the patient prior to delivering a treatment shock, and thus allows a conscious patient to delay the treatment shock. If the patient becomes unconscious, the device releases a Blue™ gel over the therapy electrodes and delivers an electrical shock to restore normal rhythm.